Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Paclitaxel and Cisplatin in Esophageal Cancer
NCT02133612Phase 2Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Dec 2007
- Primary completion
- May 2012
- Modality
- Nanoparticles, Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, Cisplatin micelle injection (HA132) in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Chinese Academy of Medical Sciences. Started Dec 2007; status: completed.
02
Drugs
Paclitaxel Micelles for InjectionCisplatin micelle injection (HA132)
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT02133612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02133612.